Li Nan-Si, Lin Weng-Ling, Hsu Ying-Pei, Chen Ying-Tzu, Shiue Yow-Ling, Yang Hung-Wei
Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
ACS Appl Bio Mater. 2019 Nov 18;2(11):4847-4855. doi: 10.1021/acsabm.9b00616. Epub 2019 Oct 11.
We herein report a facile approach for developing an enzyme-free colorimetric immunosensor based on a magnetic iron oxide (IO)-coated gold nanorod (MGNR) nanocomposite with high electron transfer ability to accelerate the color bleaching reaction of methyl orange (MO) in the presence of NaBH for ultrasensitive detection of cancer antigens. In the case of MO, the reaction rate of MGNRs showed approximately 45.6-fold and 1520.8-fold higher than that of Cys-GNRs and NaBH, respectively. The proposed colorimetric immunosensor was demonstrated to enable simple, cost-effective, sensitive, and specific carbohydrate antigen 19-9 (CA19-9) and mucin 1 (MUC1) detection for risk evaluation of pancreatic cancer (PC) with a small volume of serum sample without the use of any enhancing solutions or enzymes. By increasing the concentration of CA19-9 and MUC1, more MGNRs remained in the plate well to enhance the color bleaching of MO. As a proof-of-concept, the limit of detection (LOD) of 3.5 × 10 U/mL for CA19-9 and 5.2 × 10 U/mL for MUC1 was obtained with a wide linear quantification range from 8.6 × 10 U/mL to 1.4 × 10 U/mL for CA19-9 and 1.3 × 10 U/mL to 2.1 × 10 U/mL for MUC1, suggesting potential clinical applications for the early risk evaluation of PC.
我们在此报告一种简便的方法,用于开发一种基于磁性氧化铁(IO)包覆的金纳米棒(MGNR)纳米复合材料的无酶比色免疫传感器,该复合材料具有高电子转移能力,可在硼氢化钠(NaBH)存在下加速甲基橙(MO)的颜色漂白反应,用于超灵敏检测癌症抗原。对于MO,MGNRs的反应速率分别比半胱氨酸修饰的金纳米棒(Cys-GNRs)和NaBH的反应速率高约45.6倍和1520.8倍。所提出的比色免疫传感器被证明能够简单、经济高效、灵敏且特异性地检测糖类抗原19-9(CA19-9)和粘蛋白1(MUC1),用于胰腺癌(PC)风险评估,只需少量血清样本,无需使用任何增强溶液或酶。通过增加CA19-9和MUC1的浓度,更多的MGNRs保留在孔板中,以增强MO的颜色漂白。作为概念验证,CA19-9的检测限(LOD)为3.5×10 U/mL,MUC1的检测限为5.2×10 U/mL,CA19-9的线性定量范围为8.6×10 U/mL至1.4×10 U/mL,MUC1的线性定量范围为1.3×10 U/mL至2.1×10 U/mL,表明该方法在PC早期风险评估中具有潜在的临床应用价值。